Chinese paper, just published, not sure if it has any value though: EPA but not DHA improve systemic IR through activating muscle IL-6/AMPK pathway in high-fat diet-fed mice 2025

3 Likes

The last remaining argument in favor of DHA is some association studies such as this one from 2024: Circulating Docosahexaenoic Acid and Risk of All-Cause and Cause-Specific Mortality 2024

Massive association study:

We analyzed data from UK Biobank, which included 117,702 subjects with baseline plasma DHA levels and 12.7 years of follow-up between April 2007 and December 2021. Associations with risk for mortality endpoints were analyzed categorically by quintile of DHA plasma levels.

The results look great, except for CVD mortality (more DHA is not better). The trend is also good, but Q5 is not statistically significantly better than Q3. So it looks like as long as youā€™re not super low (Q1), youā€™re good:

Digging more into the paper, they adjusted for:

Age (years), biological sex (male, female), race (white, mixed, Asian, black), marital status (living with a partner, not living with a partner, other/unknown), employment status (not employed, low activity work, high activity work, strenuous work), education (college or higher, post high school, high school, less than high school, unknown), Townsend Deprivation Index (continuous measure of relative deprivation), physical activity (very low, low, medium, high, very high), smoking status (never, former, current, unknown), alcohol intake (daily, 3-4x/week, 1-2x/week, 1-3x/month, special occasions, never, unknown), Body Mass Index ([BMI] continuous, kg/m2), prevalent dyslipidemia (yes/no), prevalent hypertension (yes/no), prevalent diabetes (yes/no), physical activity (very low, low, medium, high, unknown), self-rated health (excellent, good, fair, poor, unknown), and total circulating omega-6 polyunsaturated fatty acid (PUFA) levels (continuous, % of total fatty acids).

So, they did not adjust for income. We know that income and omega-3 intake are associated: Omega-3 Long-Chain Polyunsaturated Fatty Acids Intake by Ethnicity, Income, and Education Level in the United States: NHANES 2003ā€“2014 2020. It is a first confounding factor. However, they adjusted for education attainment, which is correlated to income.

Other recent association studies that adjusted for income did not find benefits (or even found detrimental effects) for high-dose DHA:

They also show that serum DHA levels are highly correlated with fish oil supplementation:

Thereā€™s a massive healthy user bias here if you donā€™t adjust for fish oil supplementation: people who take fish oil are likely to be more health conscious. They probably also have a better diet, they might take other supplements, they might go to the doctor more often, they might be wealthier, etc. How come they didnā€™t adjust for that? Or just show the results stratified by self-reported fish oil use?

I also find the ~18.3% fish oil use in Q1 surprising. Itā€™s self-reported, so maybe these people use a low dose infrequently, but even with low-dose intermittent fish oil supplementation, I would expect most people to be at least in Q2 (omega 3 index around 5%). So maybe other factors impact DHA absorption that are not accounted for? DHA levels might therefore represent something else?

Then, they looked at DHA only. Indeed: ā€œBlood levels of DHA but not EPA were available in āˆ¼25% of the individuals enrolled in the UKBB.ā€ They note:

We focused on DHA in this meta-analysis as it was the only specific omega-3 fatty acid level available in the UKBB because nuclear magnetic resonance technology was not able to reliably measure plasma EPA in this population. Blood levels of DHA but not EPA show strong statistically significant inverse associations with risk of Alzheimer disease. On the other hand, EPA monotherapy has been shown to be effective in reducing risk for major adverse CV events. No similar trials of DHA monotherapy have been undertaken. Levels of EPA+DHA have been shown to be inversely associated with mortality; however, whether EPA or DHA is more strongly associated with improved life expectancy remains uncertain.

So, even them donā€™t know whatā€™s best between EPA and DHA. I guess that thereā€™s a strong correlation between EPA and DHA levels. What if the best is actually high EPA and average DHA? We just donā€™t have the data here, and we cannot conclude.

To finish, thereā€™s a risk of bias of the authors. All these association studies are always published by Oā€™Keefe and Harris. Oā€™Keefe is the Chief Medical Officer of Cardiotabs, a nutraceutical company selling omega 3 supplements. Harris works for OmegaQuant, which sells the Omega-3 Index testā€¦ What a surprise!

That paper (and other similar ones) is the only argument left in favor of DHA supplementation. And I think for the reasons explained above, itā€™s not a strong one. Especially when considering all the arguments against.

2 Likes

Iā€™m one of the people who has switched to EPA as a result of his hard work!!! *raises hand enthusiastically

Until I hear a better idea, for now Iā€™m going to supplement with DHA one day per week because I donā€™t eat fish. The thought is most of you are consuming some dha in your food, and this would help prevent me from having a deficiency.

5 Likes

Yes. I think getting rid of all DHA is a mistake. It seems to be a U-shaped curve for this one. However, EPA seems the more the better. So Iā€™ll be increasing my EPA intake and decreasing but not eliminating DHA.

2 Likes

Just pointing out that they jury may still be out re above

There could be overadjustment bias in those last studies

And given that the current study not only adjusted for education, but ALSO for 4-5 or so other variables that are correlated to income adding income to this study could lead to overadjustment bias here.

1 Like

100 mg/day of DHA is probably enough. But you get more than that with just one portion of salmon per week. So no need to supplement.

4 Likes

Which ones?

I donā€™t know about overadjustment. In any case the lack of adjustment for income isnā€™t the worst to me. The worst is the healthy user bias and the lack of presentation of results stratified by fish oil use. What if you donā€™t have any significant trends anymore when you look at fish oil users only or non fish oil users only? How come they didnā€™t present that data?

Matt Kaerberleinā€™s answer:

I donā€™t really disagree with your position, although I donā€™t find the evidence against DHA to be all that convincing. Having said that, I havenā€™t closely read all the latest literature in this space, mostly because of time constraints and also because I get frustrated at how poorly many of these studies are designed and/or analyzed.
One of the biggest limitations to most studies in this area that Iā€™ve seen is that they donā€™t actually measure omega-3ā€™s either before or after supplementation. Itā€™s tough to draw any conclusions - other than that population level supplementation probably doesnā€™t have big effects either way - in the absence of actually measuring biomarkers to see where folks started and where they ended up. If you know of good studies that did this, let me know.
Obviously, the relationship between omega-index or specific omega-3ā€™s and health outcomes is extremely complicated and impacted by genetics and other environmental (diet, exercise, etc.) factors, likely as well as whether the source comes from diet versus supplements. Even brand of supplement may matterā€¦
I do agree the evidence for benefit from supplementation tilts toward EPA for many outcomes, at least for now. The one I take is 3:1 EPA:DHA.
Honestly, like most supplements, I think the real answer is that supplementation is unlikely to move the needle much for most people. Especially if you are eating a crappy diet and donā€™t get other lifestyle factors dialed in. How much does it help if you do practice an otherwise healthy lifestyle? Hard to say, but for now it makes sense to me to get your omega-index up near the range is that most correlated with better health outcomes across populations.

I feel like he didnā€™t really read my email :sweat_smile: (at least heā€™s honest: ā€œHaving said that, I havenā€™t closely read all the latest literature in this spaceā€), but he seems to directionally agree (he takes 75% EPA).

7 Likes

Actually, checking this, many studies looked at the baseline levels and it seems that, unfortunately, supplementation is worse in people with low baseline levels!

VITAL-DEP: Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores

People with low omega 3 levels were worse off with supplementation!

This was also noted by @Neo regarding another study: ā€œThe best responders were those with higher (aggregate) initial levelsā€ Omega 3 makes me depressed: why? - #80 by Neo

So itā€™s even worse than I thoughtā€¦

2 Likes

It looks like thereā€™s a big sex based difference? There seems little effect on men? Confidence intervals for women is completely within the favoring placebo, strong effect; for men, of course straddling neutral. The thing thatā€™s interesting here is that if you eat fish, skip fish oil supplements.

However, it is also important to note: this is in regards to depression, depressive symptoms, mood disturbances. OK, but not everyone experiences such effects from EPA/DHA. On a population level, prevalence is relevant. And what does that mean? Does it affect brain health only in those who experience such symptoms from supplementing and those who donā€™t experience symptoms are unaffected?

I donā€™t supplement with DHA, but do modestly EPA (3x week, 500mg EPA). So I donā€™t know if I would get depressed if I took DHA. But if EPA supplementation also causes this effect, at least in those with low baseline levels, then it becomes a question of dosage - at what dose is this noticeable. FWIW, I donā€™t have any depressive symptoms or mood disturbances, and never had them. My modest EPA supplementation hasnā€™t changed that over the span of 2 years, which is how long Iā€™ve supplemented. But Iā€™m also male, soā€¦

2 Likes

Yes, gender effect. Women absorb omega 3 more so I guess that beneficial and detrimental effects, if any, are more obvious in women: Study: omega-3 uptake higher in women; we must account for gender in research, GOED VP says

Based on other studies (MR + RCT + animal models), DHA is the cause. Not EPA.

For what itā€™s worth Iā€™m a male with above average EPA and DHA levels and I get depression from (EPA + DHA) but not from EPA-only (even at 2 g/day).

5 Likes

Looking at this chart again, the most impressive thing is that thereā€™s not a single subgroup that benefits from 1 g/day omega 3 (EPA + DHA) over 5 years. Even at this relatively low dose, supplementation was either detrimental or absolutely useless when it came to depressive symptoms.

3 Likes